Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
All content curated by
featured
Published in Gastroenterology

Journal Scan / Research · August 01, 2023

Short-Term Efficacy of the Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant IBS

The American Journal of Gastroenterology

 

Additional Info

The American Journal of Gastroenterology
The Short-Term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism Rather Than Diversity Regulation
Am. J. Gastroenterol 2023 Jul 01;118(7)1256-1267, T Bai, Z Xu, P Xia, Y Feng, B Liu, H Liu, Y Chen, G Yan, B Lv, Z Yan, N Dai, Y Long, W Wei, Z Shi, X Li, X Fang, H Gao, L Qi, X Hou

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading